#NAAHCAD Twitter Chat, July 23rd
Join the conversation on Thursday, July 23 at 1 p.m. EST? Type #NAAHCAD in the search box of the Twitter application and click on the “latest option” to follow the twitter view.
How a Twitter Chat works
The host organization will tweet out the questions labeled T1, T2, etc. Please reply/answer a specific topic by using A1, A2, etc. in front of your tweets (eg. A1 … – this would be the beginning of the answer to Q1). After a few minutes, host organization will tweet the next question, and it continues.
- Remember to include the #NAAHCAD hashtag, which is not case sensitive, in all of your tweets – it’ll help us find your tweets and retweet you throughout the day!
- You can prepare answers to the tweets in advance or you can also tweet on the fly, re-tweet, or Like a tweet from the chat.
T1: What are the risk factors for hepatitis C? How have the prevalence of risk factors changed over time?
A1: Hepatitis C is a bloodborne infection. Risk factors include injection drug use, contact with contaminated blood, sexual transmission, and healthcare exposure. #NAAHCAD
FINALIZED QUESTIONS FOR THURSDAY, JULY 23RD
T1: What are the risk factors for hepatitis C? How has the prevalence of risk factors changed over time?
T2: Why do African-Americans still experience high rates of Hepatitis C?
T3: What are the newest screening recommendations for HCV?
T4: How do you anticipate these screening recommendations may change provider care?
T5: Are there still any “difficult to treat” populations? If so which ones?
T6: What is standing in the way of our goal to eliminate HCV?
T7: What can people living with Hep C do to protect their health, their community and prevent liver cancer?
T8: How do you plan to recognize National African American Hep C Action Day this year?
T9: How do you promote Hep C education, outreach and testing especially now during COVID19?
T10: How has COVID-19 affected hepatitis C care?
T11: What are the barriers that keep people from getting screened for hepatitis C and how can they be addressed?
T12: How can we ensure that there is funding to end the hepatitis C epidemics?